(VTR) Ventas - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92276F1003

VTR: Senior Housing, Medical Buildings, Research Centers, Healthcare Facilities

Ventas, Inc. (NYSE: VTR) is a prominent S&P 500 real estate investment trust (REIT) specializing in healthcare and senior housing properties. With a diversified portfolio of approximately 1,350 assets across North America and the United Kingdom, the company is a key player in the longevity economy, catering to the growing aging population. Ventas operates over 800 senior housing communities, including assisted living, memory care, and independent living facilities, providing essential services that enhance residents quality of life. The portfolio also includes medical office buildings, outpatient facilities, and life science properties, further solidifying its position in the healthcare real estate sector. The company leverages its operational expertise, data-driven insights from its Ventas OI platform, and strong financial position to drive performance and deliver value to stakeholders. Ventass commitment to excellence, integrity, and innovation is reflected in its focus on creating environments that support longer, healthier, and happier lives.

As of the latest data, Ventas, Inc. (NYSE: VTR) trades at $67.93 with a market capitalization of $29.73 billion. The stock exhibits a moderate trading volume, averaging 3.76 million shares over the past 20 days. Its price-earnings ratio stands at 357.53, with a forward P/E of 185.19, indicating expectations for future earnings growth. The companys price-to-book ratio is 2.76, reflecting its asset valuation. Ventass trailing 12-month price-to-sales ratio is 6.08, and its return on equity (RoE) is 0.75. The stocks technical indicators show a 20-day simple moving average (SMA) of $67.28, 50-day SMA of $66.62, and 200-day SMA of $61.26, with an average true range (ATR) of 1.83.

The stock is trading above its 200-day SMA, indicating a bullish trend. With a moderate RSI and ATR of 1.83, volatility is expected to remain manageable. Support is likely at the 50-day SMA ($66.62), with resistance near the recent high of $68.50. Expect continued upward momentum, with potential price targets of $70.00 and $72.50 over the next three months. Ventas is well-positioned to benefit from demographic tailwinds, with a focus on senior housing and healthcare properties. The companys strong balance sheet and debt-to-equity ratio of 1.16 provide flexibility for future investments. Occupancy rates in senior housing and medical office buildings are expected to stabilize, supporting cash flows. Any divestitures or acquisitions during this period could further enhance portfolio performance. Investors should monitor upcoming earnings reports for updates on occupancy trends, rental rates, and capital deployment.

Additional Sources for VTR Stock

VTR Stock Overview

Market Cap in USD 30,092m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 1998-05-04

VTR Stock Ratings

Growth Rating 69.2
Fundamental 24.7
Dividend Rating 48.1
Rel. Strength 30.3
Analysts 4.45/5
Fair Price Momentum 72.41 USD
Fair Price DCF 39.50 USD

VTR Dividends

Dividend Yield 12m 2.91%
Yield on Cost 5y 7.30%
Annual Growth 5y -3.42%
Payout Consistency 97.2%

VTR Growth Ratios

Growth Correlation 3m 46.9%
Growth Correlation 12m 82.2%
Growth Correlation 5y 47.8%
CAGR 5y 21.16%
CAGR/Max DD 5y 0.51
Sharpe Ratio 12m 1.83
Alpha 46.88
Beta 0.358
Volatility 26.04%
Current Volume 7732.2k
Average Volume 20d 2744.7k
What is the price of VTR stocks?
As of May 02, 2025, the stock is trading at USD 65.54 with a total of 7,732,160 shares traded.
Over the past week, the price has changed by -4.20%, over one month by -5.38%, over three months by +7.56% and over the past year by +54.25%.
Is Ventas a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Ventas is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VTR as of May 2025 is 72.41. This means that VTR is currently undervalued and has a potential upside of +10.48% (Margin of Safety).
Is VTR a buy, sell or hold?
Ventas has received a consensus analysts rating of 4.45. Therefor, it is recommend to buy VTR.
  • Strong Buy: 12
  • Buy: 5
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for VTR stock price target?
According to ValueRays Forecast Model, VTR Ventas will be worth about 78.4 in May 2026. The stock is currently trading at 65.54. This means that the stock has a potential upside of +19.68%.
Issuer Forecast Upside
Wallstreet Target Price 75.6 15.4%
Analysts Target Price 75.6 15.4%
ValueRay Target Price 78.4 19.7%